Simultaneous detection of IFN-gamma and IL-4 in lesional tissues and whole unstimulated saliva from patients with oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 37, Issue 2, 2008, Pages 83-87

  Tao, Xiao An ^a   Li, Chun Yang ^a   Rhodus, Nelson L ^b   Xia, Juan ^a   Yang, Xiao Ping ^a   Cheng, Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Enzyme linked immunosorbent assay; Interferon gamma; Interleukin 4; Oral lichen planus; Saliva

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LICHEN PLANUS; MALE; MOUTH DISEASE; MOUTH LESION; MOUTH LICHEN PLANUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LICHEN PLANUS; MALE; MIDDLE AGED; PILOT PROJECTS; SALIVA; STATISTICS, NONPARAMETRIC;

EID: 38149089394     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00593.x     Document Type: Article

References (33)

1. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002 13 : 350 65.
2. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002 8 : 567 73.
3. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003 32 : 77 83.
4. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-α and transforming growth factor-β mRNA in oral lichen planus. Arch Oral Biol 1999 44 : 499 507.
5. Karagouni EE, Dotsika EN, Sklavounou A. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med 1994 23 : 28 35.
6. Yamamoto T, Yoneda K, Ueta E, Hirota J, Osaki T. Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med 1991 20 : 275 9.
7. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995 104 : 784 8.
8. Kaufman E, Lamster IB. The diagnostic applications of saliva - a review. Crit Rev Oral Biol Med 2002 13 : 197 212.
9. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005 114 : 278 83.
10. Pezelj-Ribaric S, Prso IB, Abram M, Glazar I, Brumini G, Simunovic-Soskic M. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators Inflamm 2004 13 : 131 3.
11. Rhodus NL, Cheng B, Bowles W, Myers S, Miller L, Ondrey F. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis 2006 12 : 112 6.
12. Cheng B, Rhodus NL, Williams B, Griffin RJ. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 97 : 465 70.
13. Magnusson M, Pyykko I, van Setten G, Norlander T, Nastri A, Westermark A. Basic fibroblast growth factor (bFGF) in saliva and oral mucosa in patients with oral lichen planus: preliminary observations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 98 : 324 6.
14. Rodstrom PO, Jontell M, Hakeberg M, Berggren U, Lindstedt G. Erosive oral lichen planus and salivary cortisol. J Oral Pathol Med 2001 31 : 257 63.
15. Ohashi M, Iwase M, Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med 1999 28 : 355 9.
16. Yang LL, Liu XQ, Liu W, Cheng B, Li MT. Comparative analysis of whole saliva proteomes for the screening of biomarkers for oral lichen planus. Inflamm Res 2006 55 : 405 7.
17. Xie H, Rhodus NL, Griffin RJ, Carlis JV, Griffin TJ. A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 2005 4 : 1826 30.
18. Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : e1 12.
19. Tao X, Huang Y, Li R, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : 661 9.
20. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993 694 : 72 7.
21. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 1985 60 : 308 15.
22. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003 4 : 616 23.
23. Ghoreschi K, Thomas P, Breit S, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003 9 : 40 6.
24. Wurtz O, Bajenoff M, Guerder S. IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms. Int Immunol 2004 16 : 501 8.
25. Zakrzewska JM, Chan ES, Thornhill MH. A systematic review of placebo-controlled randomized clinical trials of treatments used in oral lichen planus. Br J Dermatol 2005 153 : 336 41.
26. Racke MK, Burnett D, Pak S, et al. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J Immunol 1995 154 : 450 8.
27. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992 10 : 385 409.
28. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995 16 : 34 8.
29. Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 2004 33 : 404 13.
30. Mizrachi A, Broide E, Buchs A, et al. Lack of correlation between disease activity and decreased stimulated secretion of IL-10 in lymphocytes from patients with celiac disease. Scand J Gastroenterol 2002 37 : 924 30.
31. Gor DO, Rose NR, Greenspan NS. TH1-TH2: a procrustean paradigm. Nat Immunol 2003 4 : 503 5.
32. Sommer F, Meixner M, Mannherz M, Ogilvie AL, Rollinghoff M, Lohoff M. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice. Int Immunol 1998 10 : 1853 561.
33. Lenschow D, Herold K, Rhee L, et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996 5 : 285 93.